Combined Transarterial Embolization/Chemoembolization-Based Locoregional Treatment with Sorafenib Prolongs the Survival in Patients with Advanced Hepatocellular Carcinoma and Preserved Liver Function: A Propensity Score Matching Study

BACKGROUND: Sorafenib is the standard treatment for patients with Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma (HCC). However, the treatment outcome is not satisfactory. We retrospectively analyzed whether adding transarterial embolization/chemoembolization (TA(C)E)-based lo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Liver Cancer
Main Authors: Chien, Shih-Chieh, Chen, Chiung-Yu, Cheng, Pin-Nan, Liu, Yi-Shan, Cheng, Hsiu-Chi, Chuang, Chiao-Hsiung, Chang, Ting-Tsung, Chiu, Hong-Chi, Lin, Yih-Jyh, Chiu, Yen-Cheng
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2019
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6547299/
https://ncbi.nlm.nih.gov/pubmed/31192155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000489790
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados